Latest filing published 26 May 2017 for Biohit Oyj, €5,746.
No signal scores available.
Franco Aiolfi discloses dealings in Biohit Oyj to Nasdaq Helsinki. We count 4 filings; the first trade dates from 24 February 2017 and the latest from 22 May 2017.
The open-market record consists of 3 sales worth €13k, with no purchase.
Most recently, on 26 May 2017, the filings show an open-market sale worth €5,746 in Biohit Oyj. The median gap between a trade and its publication by Nasdaq Helsinki is 5 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by Nasdaq Helsinki and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations